Market Overview

Regeneron Reports Results From Phase 3 Study Of Dupilumab In People With Severe Steroid-Dependent Asthma: 'Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: FDA

 

Related Articles (REGN + SNY)

Partner Center